ATIC


Summary: This gene encodes a bifunctional protein that catalyzes the last two steps of the de novo purine biosynthetic pathway. The N-terminal domain has phosphoribosylaminoimidazolecarboxamide formyltransferase activity, and the C-terminal domain has IMP cyclohydrolase activity. A mutation in this gene results in AICA-ribosiduria. [provided by RefSeq, Sep 2009].

Loading, please wait...
Name
OMIM ID
Ensembl ID
HGNC ID
PHARMGKB ID
Map Location

Gene Categories:

DRUGGABLE GENOME

GO terms in ATIC


Loading, please wait...
Term Type
Evidence Type
GO Term ID
GO Des.
MF TAS GO:0003937 IMP cyclohydrolase activity
MF TAS GO:0004643 phosphoribosylaminoimidazolecarboxamide formyltransferase activity
MF IPI GO:0042803 protein homodimerization activity
MF HDA GO:0045296 cadherin binding
BP IEA GO:0003360 brainstem development
BP TAS GO:0006139 nucleobase-containing compound metabolic process
Showing 1 to 6 of 20 rows rows per page

Gene expression in normal tissue: ATIC

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

Pathways in ATIC


Loading, please wait...
Database
Pathway ID
Pathway Des.
reactome R-HSA-1430728 Metabolism
reactome R-HSA-15869 Metabolism of nucleotides
reactome R-HSA-73817 Purine ribonucleoside monophosphate biosynthesis
reactome R-HSA-8956320 Nucleobase biosynthesis
humancyc PWY-6124 inosine-5,-phosphate biosynthesis
humancyc PWY-841 purine nucleotides de novo biosynthesis
Showing 1 to 6 of 29 rows rows per page

Gene-Drug: Aster Plot


Loading, please wait...
Drug ID
Drug Name
Model Num.
iGMDRD263 AACOCF3 4
iGMDRD399 Selumetinib 3
iGMDRD188 Piperlongumine 2
iGMDRD562 Navitoclax 3
Showing 1 to 4 of 18 rows rows per page

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in ATIC

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​